Sermorelin: Research History & Formulation Comparisons

How the research connects to the formula

The displayed 1984 paper gave growth-hormone-releasing factors of several chain lengths intravenously to small groups of volunteers and measured growth-hormone responses. This is a physiological response experiment, not a trial of the current catalog product’s long-term outcomes.

The exact peptide, administration route and observation period identify how closely a source connects to sermorelin. A related sequence should remain labeled as the material the investigators actually studied.

Current HealthRX.com formulation map
Product	Listed formulation	Connected ingredient research
Sermorelin	Sermorelin	Sermorelin

Publication history

When the ingredient appeared in the literature

The chart counts records mentioning the search terms in their title or abstract. It includes research beyond longevity. Use the period controls to inspect the count.

2026: 43 indexed publications. 2026 includes publications dated through October 5. The earlier bars cover longer periods than the annual bars.

View the chart as a data table

Period	Publications
1900-1959	0
1960-1969	2
1970-1979	9
1980-1989	253
1990-1999	878
2000-2009	630
2010-2014	227
2015-2019	181
2020	41
2021	54
2022	32
2023	33
2024	45
2025	46
2026	43

Search query and data source

Source: Europe PMC’s PubMed-indexed records. Retrieved October 5, 2026. The index’s firstPublicationDate field supplies the dates and chart periods; it can normalize a month-only record to the first day of the month. Dates through October 5 are included. Counts can change as the index adds or corrects records.

TITLE_ABS:((sermorelin OR "growth hormone releasing hormone")) AND SRC:MED AND FIRST_PDATE:[1900-01-01 TO 2026-10-05]

Open this literature search · Download the data

A closer search for this product question

The focused search returns 24 publications. It narrows the ingredient query to terms connected with its catalog use. Its displayed records remain a search sample, not a ranking of study quality.

View the focused query

TITLE_ABS:((sermorelin OR "growth hormone releasing hormone")) AND TITLE_ABS:(sermorelin) AND SRC:MED AND FIRST_PDATE:[1900-01-01 TO 2026-10-05]

Open the focused search

Dated publications

Read individual records in context

The timeline combines selected references with a sample from the ingredient search. Dates use the index’s firstPublicationDate field; the PubMed record may distinguish an earlier online date from the print date. Written study notes appear alongside the records that have them. Other entries show the indexed bibliography and link to the paper.

Controlled Clinical Trial · Clinical Trial · Research Support, Non-U.S. Gov't · Journal Article

Stimulation of growth hormone secretion with human growth hormone releasing factors (GRF1-44, GRF1-40, GRF1-29) in normal subjects.

Losa M, Schopohl J, Müller OA, von Werder K. Klinische Wochenschrift. PMID 6240568.

Study design: Small physiological-response experiments in volunteers
What was tested: Several human growth-hormone-releasing factors of different chain lengths, given intravenously.
What was reported: The experiments reported growth-hormone rises after the releasing-factor administrations.
How it connects to the catalog: The exact peptide sequence, intravenous route and short observation period matter. A hormone-response experiment does not establish long-term outcomes for the current sermorelin product.

Read the PubMed record · Publisher record

Study comparison

Publication	Design and regimen	Reported finding	Interpretation
1984-12-01: Stimulation of growth hormone secretion with human growth hormone releasing factors (GRF1-44, GRF1-40, GRF1-29) in normal subjects.	Small physiological-response experiments in volunteers. Several human growth-hormone-releasing factors of different chain lengths, given intravenously.	The experiments reported growth-hormone rises after the releasing-factor administrations.	The exact peptide sequence, intravenous route and short observation period matter. A hormone-response experiment does not establish long-term outcomes for the current sermorelin product.

Questions that shape the comparison

Does the source study sermorelin or another releasing factor? Is its endpoint a short-term hormone response or a clinical outcome?

Source records

Stimulation of growth hormone secretion with human growth hormone releasing factors (GRF1-44, GRF1-40, GRF1-29) in normal subjects.Losa M, Schopohl J, Müller OA, von Werder K.Klinische Wochenschrift. 1984-12-01. PMID 6240568. Controlled Clinical Trial, Clinical Trial, Research Support, Non-U.S. Gov't, Journal Article.

Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry.Uçaktürk E, Nemutlu E.Journal of pharmaceutical and biomedical analysis. 2025-10-20. PMID 41138283. Journal Article.

A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review.Coutinho LFD, DE Oliveira Neves LF, Camilo RP.The Journal of sports medicine and physical fitness. 2026-03-25. PMID 41880199. Review, Journal Article.

The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.Dominikowski A, Rękoś Z, Olejarz M, Szczepanek-Parulska E, Domin R, RuchaŁa M.Frontiers in endocrinology. 2026-06-18. PMID 42395176. review-article, Review, Journal Article.

Acromegaly Secondary to Ectopic Growth Hormone-Releasing Hormone Secretion From Metastatic Bronchial Carcinoid Tumor: A Case Report.Anees SF, Abid IA.Cureus. 2026-07-09. PMID 42571548. Journal Article, Case Reports, case-report.

Growth hormone - releasing hormone antagonists protect endothelial corneal cells against lipopolysaccharides-induced inflammation.Sarker MMR, Fakir S, Sigdel M, Jackson K, Barabutis N.Experimental eye research. 2026-07-15. PMID 42456877. Journal Article.

Structural adaptation associated with signaling preference at the human Growth Hormone-Releasing Hormone Receptor.Wang MW, Hang K, Qiu Y, Chen X, Chen Y, Huang S, Cong Z, Zhou Q.Protein & cell. 2026-09-01. PMID 41849435. letter, Journal Article.

Growth hormone-releasing hormone, growth hormone, and neuroendocrine tumors.Shahid M, Koch CA.Journal of clinical & translational endocrinology. 2026-09-11. PMID 42774755. review-article, Review, Journal Article.

Research data assembled by HealthRX.com from the displayed source records, October 5, 2026. The atlas contains a dated literature search and selected studies; it is not an exhaustive systematic review.